Biomarkers for prostate cancer metastasis
US7482123B2 · kind B2 · utility
2Cited by
0References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 4, 2005 |
| Grant date | Jan 27, 2009 |
| Priority date | — |
| Expiry date | Nov 4, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/136
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention provides genomic markers for determining the predisposition of prostate cancer to become metastasized.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.